Medicines Co. (MDCO) Receives Marketing Approval from EC for Three Products
Tweet Send to a Friend
Medicines Co. (NASDAQ: MDCO) announced that the European Commission has granted marketing authorization for three of its hospital acute care ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE